Title : Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.

Pub. Date : 2005 May 9

PMID : 15910809






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Alemtuzumab, a monoclonal anti-CD52 antibody has been shown to be highly effective in B-cell chronic lymphocytic leukemia, even in fludarabine-refractory disease. fludarabine CD52 molecule Homo sapiens